Literature DB >> 22081143

A new target for personalized medicine.

Philip Hunter.   

Abstract

Mesh:

Substances:

Year:  2011        PMID: 22081143      PMCID: PMC3245705          DOI: 10.1038/embor.2011.219

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


× No keyword cloud information.
  6 in total

Review 1.  Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug.

Authors:  Paul A Marks; Ronald Breslow
Journal:  Nat Biotechnol       Date:  2007-01       Impact factor: 54.908

Review 2.  The gene Pax4 is an essential regulator of pancreatic beta-cell development.

Authors:  Beatriz Sosa-Pineda
Journal:  Mol Cells       Date:  2004-12-31       Impact factor: 5.034

3.  Small-molecule inducers of insulin expression in pancreatic alpha-cells.

Authors:  Dina Fomina-Yadlin; Stefan Kubicek; Deepika Walpita; Vlado Dancik; Jacob Hecksher-Sørensen; Joshua A Bittker; Tanaz Sharifnia; Alykhan Shamji; Paul A Clemons; Bridget K Wagner; Stuart L Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-09       Impact factor: 11.205

4.  Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse.

Authors:  Patrick O McGowan; Aya Sasaki; Ana C D'Alessio; Sergiy Dymov; Benoit Labonté; Moshe Szyf; Gustavo Turecki; Michael J Meaney
Journal:  Nat Neurosci       Date:  2009-03       Impact factor: 24.884

5.  Plastic and evolved responses of larval tracheae and mass to varying atmospheric oxygen content in Drosophila melanogaster.

Authors:  Joanna R Henry; Jon F Harrison
Journal:  J Exp Biol       Date:  2004-09       Impact factor: 3.312

Review 6.  Histone deacetylase inhibitors in cancer therapy.

Authors:  Andrew A Lane; Bruce A Chabner
Journal:  J Clin Oncol       Date:  2009-10-13       Impact factor: 44.544

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.